Characterization of bispecific antibodies that drive synthetic agonistic receptor - transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models. (March 2019) - Benmebarek, M.; Karches, C.H.; Schmidbauer, M.L.; Kurzay, M.; Klaus, R.; Geiger, M.; Rataj, F.; Cadilha, B.; Lesch, S.; Heise, C.; Murr, R.; Berg, J.vom; et al.